A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is a highly heterogeneous disease, for which prognosis has been relegated to clinicopathologic staging for decades. There is a need to stratify subpopulations of CRC on a molecular basis to better predict outcome and assign therapies. Here we report targeted exome-sequencing of 1,321 cancer-related genes on 468 tumour specimens, which identified a subset of 17 genes that best classify CRC, with APC playing a central role in predicting overall survival. APC may assume 0, 1 or 2 truncating mutations, each with a striking differential impact on survival. Tumours lacking any APC mutation carry a worse prognosis than single APC mutation tumours; however, two APC mutation tumours with mutant KRAS and TP53 confer the poorest survival among all the subgroups examined. Our study demonstrates a prognostic role for APC and suggests that sequencing of APC may have clinical utility in the routine staging and potential therapeutic assignment for CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Approximately 55% of colorectal cancers (CRCs) are driven by mutational activation of KRAS, BRAF, NRAS, and thus are hard-wired to oncogenic RAS/RAF/MEK/ERK pathway signaling [1–3].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · cited 3×
“Using the recently reported CMS classification system 36 , we found that CMS1, instead of CMS4 MSS tumours, were significantly associated with worse survival.”
InfluentialMicrosatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Douillard, J.-Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305275 · Cited by 2,263
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001453 · Cited by 1,507
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158
Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Srivastava, S., Jass, J. R., Khan, P. M., Lynch, H., Smyrk, T., Perucho, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1758 · Cited by 1,137
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063 · cited 2×
“1B), supporting the notion that these CRC types undergo tumorigenesis through very different genetic mechanisms, and, accordingly, have different clinical outcomes 22,23 .”
InfluentialTumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
Koo, B.-K., Spit, M., Jordens, I., Low, T. Y., Stange, D. E., van de Wetering, M., van Es, J. H., Mohammed, S., Heck, A. J. R., Maurice, M. M., et al. (2012) · Nature · doi:10.1038/nature11308 · Cited by 980
Sadanandam, A., Lyssiotis, C. A., Homicsko, K., Collisson, E. A., Gibb, W. J., Wullschleger, S., Ostos, L. C. G., Lannon, W. A., Grotzinger, C., Del Rio, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3175 · Cited by 960
APC, Signal transduction and genetic instability in colorectal cancer
Fodde, R., Smits, R., & Clevers, H. (2001) · Nature Reviews Cancer · doi:10.1038/35094067 · Cited by 937 · cited 3×
“This is in accord with the double mutation profile established by others 26,27 , more specifically for FAP colon cancers.”
InfluentialComparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 818
De Sousa E Melo, F., Wang, X., Jansen, M., Fessler, E., Trinh, A., de Rooij, L. P. M. H., de Jong, J. H., de Boer, O. J., van Leersum, R., Bijlsma, M. F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3174 · Cited by 771
Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers
Samowitz, W. S., Sweeney, C., Herrick, J., Albertsen, H., Levin, T. R., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0404 · Cited by 737
Rowan, A. J., Lamlum, H., Ilyas, M., Wheeler, J., Straub, J., Papadopoulou, A., Bicknell, D., Bodmer, W. F., & Tomlinson, I. P. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3352 · Cited by 500
RNF43 is frequently mutated in colorectal and endometrial cancers
Giannakis, M., Hodis, E., Jasmine Mu, X., Yamauchi, M., Rosenbluh, J., Cibulskis, K., Saksena, G., Lawrence, M. S., Qian, Z. R., Nishihara, R., et al. (2014) · Nature Genetics · doi:10.1038/ng.3127 · Cited by 470
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
Budinska, E., Popovici, V., Tejpar, S., D'Ario, G., Lapique, N., Sikora, K. O., Di Narzo, A. F., Yan, P., Hodgson, J. G., Weinrich, S., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4212 · Cited by 409
Albuquerque, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1549 · Cited by 392
Roepman, P., Schlicker, A., Tabernero, J., Majewski, I., Tian, S., Moreno, V., Snel, M. H., Chresta, C. M., Rosenberg, R., Nitsche, U., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28387 · Cited by 346
EMT is the dominant program in human colon cancer
Loboda, A., Nebozhyn, M. V., Watters, J. W., Buser, C. A., Shaw, P. M., Huang, P. S., Van't Veer, L., Tollenaar, R. A., Jackson, D. B., Agrawal, D., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-9 · Cited by 274 · cited 4×
“In support of this notion, our previous study showed that EMT was inversely associated with RAS activity 17 .”
InfluentialSelf-citationOgino, S., Shima, K., Meyerhardt, J. A., McCleary, N. J., Ng, K., Hollis, D., Saltz, L. B., Mayer, R. J., Schaefer, P., Whittom, R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2246 · Cited by 267
Fariña-Sarasqueta, A., van Lijnschoten, G., Moerland, E., Creemers, G.-J., Lemmens, V. E. P. P., Rutten, H. J. T., & van den Brule, A. J. C. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq258 · Cited by 263
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Dry, J. R., Pavey, S., Pratilas, C. A., Harbron, C., Runswick, S., Hodgson, D., Chresta, C., McCormack, R., Byrne, N., Cockerill, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1577 · Cited by 262 · cited 3×
“EMT and RAS signature scores were previously developed 16,17 and calculated in 468 samples similarly as described in our recent report 29 .”
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
Conlin, A., Smith, G., Carey, F. A., Wolf, C. R., & Steele, R. J. C. (2005) · Gut · doi:10.1136/gut.2005.066514 · Cited by 261
The nonrandom participation of human acrocentric chromosomes in Robertsonian translocations
Therman, E., Susman, B., & Denniston, C. (1989) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1989.tb01121.x · Cited by 247
Rad, R., Cadiñanos, J., Rad, L., Varela, I., Strong, A., Kriegl, L., Constantino-Casas, F., Eser, S., Hieber, M., Seidler, B., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.014 · Cited by 216
Herbst, A., Jurinovic, V., Krebs, S., Thieme, S. E., Blum, H., Göke, B., & Kolligs, F. T. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-74 · Cited by 212
Hiltunen, M., Alhonen, L. I., Koıstınaho, J., Myöhänen, S., Pääkkönen, M. E., Marin, S., Kosma, V.-M., & Jänne, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970317)70:6<644::aid-ijc3>3.0.co;2-v · Cited by 208
APC mutation and tumour budding in colorectal cancer
Jass, J. R., Barker, M., Fraser, L., Walsh, M. D., Whitehall, V. L. J., Gabrielli, B., Young, J., & Leggett, B. A. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.1.69 · Cited by 160
Colorectal cancer with and without microsatellite instability involves different genes
Salahshor, S., Kressner, U., P�hlman, L., Glimelius, B. L. G., Lindmark, G. E., & Lindblom, A. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199911)26:3<247::aid-gcc9>3.0.co;2-h · Cited by 154
Christie, M., Jorissen, R. N., Mouradov, D., Sakthianandeswaren, A., Li, S., Day, F., Tsui, C., Lipton, L., Desai, J., Jones, I. T., et al. (2013) · Oncogene · doi:10.1038/onc.2012.486 · Cited by 151
APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer
Samowitz, W. S., Slattery, M. L., Sweeney, C., Herrick, J. S., Wolff, R. K., & Albertsen, H. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0398 · Cited by 149
Crabtree, M., Sieber, O. M., Lipton, L. R., Hodgson, S. V., Lamlum, H., Thomas, H. J. W., Neale, K. F., Phillips, R. K. S., Heinimann, K., & Tomlinson, I. P. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206471 · Cited by 110
APC shuttling to the membrane, nucleus and beyond
Brocardo, M. G., & Henderson, B. R. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.09.002 · Cited by 106
Histological Grading of Rectal Cancer
Dukes, C. (1937) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591573703000412 · Cited by 87
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
Domingo, E., Ramamoorthy, R., Oukrif, D., Rosmarin, D., Presz, M., Wang, H., Pulker, H., Lockstone, H., Hveem, T., Cranston, T., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4139 · Cited by 79
Chen, J., Röcken, C., Lofton-Day, C., Schulz, H., Müller, O., Kutzner, N., Malfertheiner, P., & Ebert, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh280 · Cited by 75
Loregger, A., Grandl, M., Mejías‐Luque, R., Allgäuer, M., Degenhart, K., Haselmann, V., Oikonomou, C., Hatzis, P., Janssen, K., Nitsche, U., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aac6757 · Cited by 75
A novel function of adenomatous polyposis coli (APC) in regulating DNA repair
Jaiswal, A. S., & Narayan, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.024 · Cited by 74
Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF
Thiel, A., & Ristimäki, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00281 · Cited by 70
Narayan, S., Jaiswal, A. S., & Balusu, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409200200 · Cited by 62
Segditsas, S., Sieber, O. M., Rowan, A., Setién, F., Neale, K. F., Phillips, R. K. S., Ward, R. L., Esteller, M., & Tomlinson, I. P. M. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.09.006 · Cited by 53
Zebisch, M., & Jones, E. Y. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.04.006 · Cited by 51
Mechanism of Adenomatous Polyposis Coli (APC)-Mediated Blockage of Long-Patch Base Excision Repair
Jaiswal, A. S., Balusu, R., Armas, M. L., Kundu, C. N., & Narayan, S. (2006) · Biochemistry · doi:10.1021/bi0607958 · Cited by 44
Kim, R., Schell, M. J., Teer, J. K., Greenawalt, D. M., Yang, M., & Yeatman, T. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126670 · Cited by 44
Self-citationSchell, M. J., Yang, M., Missiaglia, E., Delorenzi, M., Soneson, C., Yue, B., Nebozhyn, M. V., Loboda, A., Bloom, G., & Yeatman, T. J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0143 · Cited by 42
Self-citationOkahashi, N., Murase, Y., Koseki, T., Sato, T., Yamato, K., & Nishihara, T. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010301)80:3<360::aid-jcb90>3.0.co;2-x · Cited by 42
Hermans, M. M. P., Kroos, M. A., Smeitink, J. A. M., van der Ploeg, A. T., Kleijer, W. J., & Reuser, A. J. J. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:3<209::aid-humu5>3.0.co;2-c · Cited by 27
Jaiswal, A. S., & Narayan, S. (2011) · Biochemistry · doi:10.1021/bi102000q · Cited by 24
Curia, M. C., Esposito, D. L., Aceto, G. M., Palmirotta, R., Crognale, S., Valanzano, R., Ficari, F., Tonelli, F., Battista, P., Mariani‐Costantini, R., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:3<197::aid-humu3>3.0.co;2-f · Cited by 23
Sakamoto, Y., Kitazawa, R., Maeda, S., & Kitazawa, S. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010301)80:3<415::aid-jcb150>3.0.co;2-5 · Cited by 15
Guo, Y., Lee, J. H., Shu, L., Huang, Y. S., Li, W., Zhang, C., Yang, Y., Boyanapalli, S. S. S., Perekatt, A. O., Hart, R. P., et al. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0013-2 · Cited by 12
Jaiswal, A. S., Armas, M. L., Izumi, T., Strauss, P. R., & Narayan, S. (2012) · Neoplasia · doi:10.1593/neo.12680 · Cited by 11
Jaiswal, A. S., Panda, H., Pampo, C., Siemann, D. W., Gairola, C. G., Hromas, R., & Narayan, S. (2013) · Neoplasia · doi:10.1593/neo.13176 · Cited by 10
Cited by
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
Yaeger, R., Chatila, W. K., Lipsyc, M. D., Hechtman, J. F., Cercek, A., Sanchez-Vega, F., Jayakumaran, G., Middha, S., Zehir, A., Donoghue, M. T. A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.004 · Cited by 858
“In our model, we considered APC oncogenic alterations as a single group, but further analysis with larger datasets may be able to refine the positive prognostic effect of APC alterations, as recent data suggest that the number of APC alterations also affects survival (Schell et al., 2016).”
MethodMutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466
Lu, Y., Zhao, X., Liu, Q., Li, C., Graves-Deal, R., Cao, Z., Singh, B., Franklin, J. L., Wang, J., Hu, H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4424 · Cited by 425
Self-citationJung, Y.-S., & Park, J.-I. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0380-6 · Cited by 419
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes
Lee, M. S., Menter, D. G., & Kopetz, S. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0038 · Cited by 379
Metadata
- Authors
- Schell, M. J., Yang, M., Teer, J. K., Lo, F. Y., Madan, A., Coppola, D., Monteiro, A. N. A., Nebozhyn, M. V., Yue, B., Loboda, A., Bien-Willner, G. A., Greenawalt, D. M., & Yeatman, T. J.
- Affiliations
- Moffitt Cancer Center (US)
- LabCorp (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Schell, Michael J.
- Yeatman, Timothy J.
- ORCID
- Venue
- Nature Communications
- Published
- 2016-06-15
- Volume
- 7
- Issue
- 1
- Pages
- 11743-11743
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4912618
- OpenAlex
- W2421455087
- Cited by
- 207
- References
- 63
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 21 · 2022: 31 · 2021: 32 · 2020: 31 · 2019: 19 · 2018: 16 · 2017: 16 · 2016: 3
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Moffitt Cancer Center (P30-CA76292)
- National Institutes of Health
- National Cancer Institute (P30‐CA76292, CA76292, U01CA157960, P30CA076292)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- colorectal cancer, APC mutation, prognostic factors, overall survival, KRAS, TP53, truncating mutations, molecular subtyping, targeted exome sequencing, treatment stratification
- MeSH terms
- Cell Nucleus, Humans, Mutation, Neoplasm Metastasis, Prognosis, Staining and Labeling, Colorectal Neoplasms, Proportional Hazards Models, Statistics, Nonparametric, Adenomatous Polyposis Coli Protein, Wnt Proteins, beta Catenin, Genes, Neoplasm, Kaplan-Meier Estimate, Microsatellite Instability, Mutation Rate, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.